Insider Transactions in Q1 2022 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2022
|
James R. Kasinger General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,039
-2.19%
|
$63,379
$61.08 P/Share
|
|
Mar 14
2022
|
Lawrence Otto Klein CBO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,229
-4.39%
|
$74,969
$61.08 P/Share
|
|
Mar 14
2022
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,153
-1.41%
|
$253,333
$61.08 P/Share
|
|
Mar 11
2022
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+4.53%
|
-
|
|
Mar 11
2022
|
James R. Kasinger General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,321
-2.84%
|
$81,902
$62.56 P/Share
|
|
Mar 11
2022
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+9.67%
|
-
|
|
Mar 11
2022
|
Lawrence Otto Klein CBO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,883
-7.0%
|
$116,746
$62.56 P/Share
|
|
Mar 11
2022
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+2.97%
|
-
|
|
Mar 11
2022
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,487
-1.89%
|
$340,194
$62.56 P/Share
|
|
Mar 10
2022
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,834
+5.74%
|
-
|
|
Mar 10
2022
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,584
+14.56%
|
-
|
|
Mar 10
2022
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,834
+3.91%
|
-
|